1107 related articles for article (PubMed ID: 31972425)
41. JAK inhibition and progressive kidney disease.
Brosius FC; He JC
Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):88-95. PubMed ID: 25415616
[TBL] [Abstract][Full Text] [Related]
42. JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians.
Stabile H; Scarno G; Fionda C; Gismondi A; Santoni A; Gadina M; Sciumè G
Immunol Rev; 2018 Nov; 286(1):148-159. PubMed ID: 30294965
[TBL] [Abstract][Full Text] [Related]
43. Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy.
Mahjoor M; Mahmoudvand G; Farokhi S; Shadab A; Kashfi M; Afkhami H
Cell Commun Signal; 2023 Oct; 21(1):272. PubMed ID: 37784164
[TBL] [Abstract][Full Text] [Related]
44. Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.
Bharadwaj U; Kasembeli MM; Robinson P; Tweardy DJ
Pharmacol Rev; 2020 Apr; 72(2):486-526. PubMed ID: 32198236
[TBL] [Abstract][Full Text] [Related]
45. The JAK/STAT signaling pathway: from bench to clinic.
Hu X; Li J; Fu M; Zhao X; Wang W
Signal Transduct Target Ther; 2021 Nov; 6(1):402. PubMed ID: 34824210
[TBL] [Abstract][Full Text] [Related]
46. The JAK-STAT pathway: a therapeutic target in hematological malignancies.
Ferrajoli A; Faderl S; Ravandi F; Estrov Z
Curr Cancer Drug Targets; 2006 Dec; 6(8):671-9. PubMed ID: 17168672
[TBL] [Abstract][Full Text] [Related]
47. Development of JAK inhibitors for the treatment of immune-mediated diseases: kinase-targeted inhibitors and pseudokinase-targeted inhibitors.
Kim HO
Arch Pharm Res; 2020 Nov; 43(11):1173-1186. PubMed ID: 33161563
[TBL] [Abstract][Full Text] [Related]
48. The molecular details of cytokine signaling via the JAK/STAT pathway.
Morris R; Kershaw NJ; Babon JJ
Protein Sci; 2018 Dec; 27(12):1984-2009. PubMed ID: 30267440
[TBL] [Abstract][Full Text] [Related]
49. The JAK-STAT Signaling Pathway in Epilepsy.
Sun H; Ma D; Cheng Y; Li J; Zhang W; Jiang T; Li Z; Li X; Meng H
Curr Neuropharmacol; 2023; 21(10):2049-2069. PubMed ID: 36518035
[TBL] [Abstract][Full Text] [Related]
50. Small molecule drug discovery targeting the JAK-STAT pathway.
Lv Y; Mi P; Babon JJ; Fan G; Qi J; Cao L; Lang J; Zhang J; Wang F; Kobe B
Pharmacol Res; 2024 Jun; 204():107217. PubMed ID: 38777110
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of JAK/STAT signaling pathway prevents high-glucose-induced increase in endothelin-1 synthesis in human endothelial cells.
Manea SA; Manea A; Heltianu C
Cell Tissue Res; 2010 Apr; 340(1):71-9. PubMed ID: 20217138
[TBL] [Abstract][Full Text] [Related]
52. JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications.
Springuel L; Renauld JC; Knoops L
Haematologica; 2015 Oct; 100(10):1240-53. PubMed ID: 26432382
[TBL] [Abstract][Full Text] [Related]
53. Phytochemicals Targeting JAK-STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models.
Moon SY; Kim KD; Yoo J; Lee JH; Hwangbo C
Molecules; 2021 May; 26(9):. PubMed ID: 34068714
[TBL] [Abstract][Full Text] [Related]
54. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer.
Xue C; Yao Q; Gu X; Shi Q; Yuan X; Chu Q; Bao Z; Lu J; Li L
Signal Transduct Target Ther; 2023 May; 8(1):204. PubMed ID: 37208335
[TBL] [Abstract][Full Text] [Related]
55. The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension.
Roger I; Milara J; Montero P; Cortijo J
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067108
[TBL] [Abstract][Full Text] [Related]
56. Dynamics and non-canonical aspects of JAK/STAT signalling.
Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
[TBL] [Abstract][Full Text] [Related]
57. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.
Groner B; von Manstein V
Mol Cell Endocrinol; 2017 Aug; 451():1-14. PubMed ID: 28576744
[TBL] [Abstract][Full Text] [Related]
58. Potential therapeutic effects of curcumin mediated by JAK/STAT signaling pathway: A review.
Ashrafizadeh M; Rafiei H; Mohammadinejad R; Afshar EG; Farkhondeh T; Samarghandian S
Phytother Res; 2020 Aug; 34(8):1745-1760. PubMed ID: 32157749
[TBL] [Abstract][Full Text] [Related]
59. Janus kinases: an ideal target for the treatment of autoimmune diseases.
Gadina M
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S70-2. PubMed ID: 24326567
[TBL] [Abstract][Full Text] [Related]
60. JAK-STAT Signaling and Beyond in the Pathogenesis of Spondyloarthritis and Their Clinical Significance.
Raychaudhuri SP; Shah RJ; Banerjee S; Raychaudhuri SK
Curr Rheumatol Rep; 2024 Jun; 26(6):204-213. PubMed ID: 38492148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
